Association of labor epidural analgesia exposure with long-term risk of autism spectrum disorder in offspring: A meta-analysis of observational studies.
Labor epidurals show a flimsy, inconsistent tie to autism that is too weak to guide care.
01Research in Context
What this study did
The team pooled earlier papers that tracked kids whose moms had an epidural during labor. They asked: do these children get autism more often?
They only kept studies that compared epidural versus no-epidural groups and recorded later autism diagnoses.
What they found
A tiny bump in autism odds showed up, but the size was so small it could easily be noise.
The link got weaker when the researchers looked at longer follow-ups or tighter study designs.
Overall, they rated the evidence quality as very low.
How this fits with other research
Gale et al. (2003) looked at Pitocin, another labor drug, and found zero extra autism cases. The drugs differ, so the two findings do not truly clash, but together they cool the idea that labor meds drive autism.
Xu et al. (2014) and Zhu et al. (2020) saw clearer, modest risk jumps from maternal diabetes or autoimmune disease. Those conditions affect the fetus for months, while an epidural lasts hours—helping explain why the epidural signal is even smaller.
Marí-Bauset et al. (2022) warn that most prenatal chemical studies, like this one, share weak designs and hidden confounds. Their message: do not change practice until stronger data arrive.
Why it matters
You can reassure worried parents that labor epidurals are not a proven autism trigger. Keep the focus on known, modifiable risks such as maternal diabetes or post-term jaundice, and stay alert for new high-quality evidence rather than acting on shaky links.
Want CEUs on This Topic?
The ABA Clubhouse has 60+ free CEUs — live every Wednesday. Ethics, supervision & clinical topics.
Join Free →When parents ask if the epidural caused autism, say current data show no meaningful link and steer talk to proven developmental supports.
02At a glance
03Original abstract
A previous meta-analysis has demonstrated a superior analgesic efficacy of epidural analgesia (e.g. labor epidural analgesia) in comparison with non-epidural approaches. The widely accepted safety of labor epidural analgesia also endorses its current popularity in obstetric practice. However, the results of a recent large-scale longitudinal study that demonstrated a significant increase in risk of autism spectrum disorder in offspring from mothers with labor epidural analgesia exposure have raised some concerns over the safety of its use. The current meta-analysis aimed at examining the strength of evidence regarding this issue based on updated clinical data. Through systematically reviewing seven eligible observational studies involving 4,021,406 children from electronic databases, our results showed a slight but statistically significant increase in risk of autism spectrum disorder in children with exposure to labor epidural analgesia compared with those without. The finding was consistent in subgroup analysis focusing on siblings and children delivered vaginally. Nevertheless, despite the tendency of an increased risk of autism spectrum disorder in children exposed to labor epidural analgesia <4 h, this effect was not observed in those exposed to labor epidural analgesia >8 h (data from two studies). In conclusion, the level of evidence linking labor epidural analgesia to autism spectrum disorder development in offspring was very low based on the latest data because of the small effect size and the finding of a lack of cumulative dose-response effect in the current analysis. Further studies are warranted to provide an insight into this issue.
Autism : the international journal of research and practice, 2023 · doi:10.1177/13623613221138690